A citation-based method for searching scientific literature

Walter Ling, Maureen Hillhouse, Catherine Domier, Geetha Doraimani, Jeremy Hunter, Christie Thomas, Jessica Jenkins, Albert Hasson, Jeffrey Annon, Andrew Saxon, Jeffrey Selzer, Joshua Boverman, Richard Bilangi. Addiction 2009
Times Cited: 84







List of co-cited articles
632 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network.
Walter Ling, Leslie Amass, Steve Shoptaw, Jeffrey J Annon, Maureen Hillhouse, Dean Babcock, Greg Brigham, Judy Harrer, Malcolm Reid, Joan Muir,[...]. Addiction 2005
164
40

Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial.
George E Woody, Sabrina A Poole, Geetha Subramaniam, Karen Dugosh, Michael Bogenschutz, Patrick Abbott, Ashwin Patkar, Mark Publicker, Karen McCain, Jennifer Sharpe Potter,[...]. JAMA 2008
243
36

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.
Roger D Weiss, Jennifer Sharpe Potter, David A Fiellin, Marilyn Byrne, Hilary S Connery, William Dickinson, John Gardin, Margaret L Griffin, Marc N Gourevitch, Deborah L Haller,[...]. Arch Gen Psychiatry 2011
339
29

Clinical pharmacology of buprenorphine: ceiling effects at high doses.
S L Walsh, K L Preston, M L Stitzer, E J Cone, G E Bigelow. Clin Pharmacol Ther 1994
522
20


Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.
Paul J Fudala, T Peter Bridge, Susan Herbert, William O Williford, C Nora Chiang, Karen Jones, Joseph Collins, Dennis Raisch, Paul Casadonte, R Jeffrey Goldsmith,[...]. N Engl J Med 2003
372
16

The Clinical Opiate Withdrawal Scale (COWS).
Donald R Wesson, Walter Ling. J Psychoactive Drugs 2003
525
16

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.
W Ling, C Charuvastra, J F Collins, S Batki, L S Brown, P Kintaudi, D R Wesson, L McNicholas, D J Tusel, U Malkerneker,[...]. Addiction 1998
279
15

A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.
W K Bickel, M L Stitzer, G E Bigelow, I A Liebson, D R Jasinski, R E Johnson. Clin Pharmacol Ther 1988
233
15



A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers.
Stacey C Sigmon, Kelly E Dunn, Kathryn Saulsgiver, Mollie E Patrick, Gary J Badger, Sarah H Heil, John R Brooklyn, Stephen T Higgins. JAMA Psychiatry 2013
54
22

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
Leslie Amass, Walter Ling, Thomas E Freese, Chris Reiber, Jeffrey J Annon, Allan J Cohen, Dennis McCarty, Malcolm S Reid, Lawrence S Brown, Cynthia Clark,[...]. Am J Addict 2004
106
13

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.
David A Fiellin, Michael V Pantalon, Marek C Chawarski, Brent A Moore, Lynn E Sullivan, Patrick G O'Connor, Richard S Schottenfeld. N Engl J Med 2006
240
13

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
R P Mattick, J Kimber, C Breen, M Davoli. Cochrane Database Syst Rev 2008
405
11

The Fifth Edition of the Addiction Severity Index.
A T McLellan, H Kushner, D Metzger, R Peters, I Smith, G Grissom, H Pettinati, M Argeriou. J Subst Abuse Treat 1992
11

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Richard P Mattick, Courtney Breen, Jo Kimber, Marina Davoli. Cochrane Database Syst Rev 2014
864
11

A comparison of buprenorphine taper outcomes between prescription opioid and heroin users.
Suzanne Nielsen, Maureen Hillhouse, Christie Thomas, Albert Hasson, Walter Ling. J Addict Med 2013
33
30

Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.
W K Bickel, M L Stitzer, G E Bigelow, I A Liebson, D R Jasinski, R E Johnson. J Pharmacol Exp Ther 1988
185
10


Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.
Joshua D Lee, Edward V Nunes, Patricia Novo, Ken Bachrach, Genie L Bailey, Snehal Bhatt, Sarah Farkas, Marc Fishman, Phoebe Gauthier, Candace C Hodgkins,[...]. Lancet 2018
341
10

Pharmacokinetics of the combination tablet of buprenorphine and naloxone.
C Nora Chiang, Richard L Hawks. Drug Alcohol Depend 2003
128
9

A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.
R E Johnson, T Eissenberg, M L Stitzer, E C Strain, I A Liebson, G E Bigelow. Drug Alcohol Depend 1995
139
9

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
W Ling, D R Wesson, C Charuvastra, C J Klett. Arch Gen Psychiatry 1996
276
9

Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Jessica M Peirce, Nancy M Petry, Maxine L Stitzer, Jack Blaine, Scott Kellogg, Frank Satterfield, Marion Schwartz, Joe Krasnansky, Eileen Pencer, Lolita Silva-Vazquez,[...]. Arch Gen Psychiatry 2006
236
9

The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review.
Kelly E Dunn, Stacey C Sigmon, Eric C Strain, Sarah H Heil, Stephen T Higgins. Drug Alcohol Depend 2011
41
19

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.
Douglas M Ziedonis, Leslie Amass, Marc Steinberg, George Woody, Jonathan Krejci, Jeffrey J Annon, Allan J Cohen, Nancy Waite-O'Brien, Susan M Stine, Dennis McCarty,[...]. Drug Alcohol Depend 2009
46
15

Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers.
Mark K Greenwald, Chris-Ellyn Johanson, David E Moody, James H Woods, Michael R Kilbourn, Robert A Koeppe, Charles R Schuster, Jon-Kar Zubieta. Neuropsychopharmacology 2003
186
8

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.
Sandra D Comer, Maria A Sullivan, Elmer Yu, Jami L Rothenberg, Herbert D Kleber, Kyle Kampman, Charles Dackis, Charles P O'Brien. Arch Gen Psychiatry 2006
243
8


Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
Nancy M Petry, Jessica M Peirce, Maxine L Stitzer, Jack Blaine, John M Roll, Allan Cohen, Jeanne Obert, Therese Killeen, Michael E Saladin, Mark Cowell,[...]. Arch Gen Psychiatry 2005
265
8

Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users.
Theresa Winhusen, Frankie Kropp, Dean Babcock, Diane Hague, Sarah J Erickson, Connie Renz, Leela Rau, Daniel Lewis, Jeff Leimberger, Eugene Somoza. J Subst Abuse Treat 2008
65
10

Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study.
Kathleen M Carroll, Samuel A Ball, Charla Nich, Steve Martino, Tami L Frankforter, Christiane Farentinos, Lynn E Kunkel, Susan K Mikulich-Gilbertson, Jon Morgenstern, Jeanne L Obert,[...]. Drug Alcohol Depend 2006
257
8

Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics.
Samuel A Ball, Steve Martino, Charla Nich, Tami L Frankforter, Deborah Van Horn, Paul Crits-Christoph, George E Woody, Jeanne L Obert, Christiane Farentinos, Kathleen M Carroll. J Consult Clin Psychol 2007
125
8

Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Lisa A Marsch, Warren K Bickel, Gary J Badger, Marne E Stothart, Kimberly J Quesnel, Catherine Stanger, John Brooklyn. Arch Gen Psychiatry 2005
117
8

Neonatal abstinence syndrome after methadone or buprenorphine exposure.
Hendrée E Jones, Karol Kaltenbach, Sarah H Heil, Susan M Stine, Mara G Coyle, Amelia M Arria, Kevin E O'Grady, Peter Selby, Peter R Martin, Gabriele Fischer. N Engl J Med 2010
565
8

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
Evgeny Krupitsky, Edward V Nunes, Walter Ling, Ari Illeperuma, David R Gastfriend, Bernard L Silverman. Lancet 2011
342
8

A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology.
Roger D Weiss, Jennifer Sharpe Potter, Scott E Provost, Zhen Huang, Petra Jacobs, Albert Hasson, Robert Lindblad, Hilary Smith Connery, Kristi Prather, Walter Ling. Contemp Clin Trials 2010
58
12

Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.
David A Fiellin, Richard S Schottenfeld, Christopher J Cutter, Brent A Moore, Declan T Barry, Patrick G O'Connor. JAMA Intern Med 2014
117
8

A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
Johan Kakko, Leif Grönbladh, Kerstin Dybrandt Svanborg, Joachim von Wachenfeldt, Christian Rück, Bob Rawlings, Lars-Håkan Nilsson, Markus Heilig. Am J Psychiatry 2007
113
7

Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence.
Alexander Elkader, Beth Sproule. Clin Pharmacokinet 2005
188
7

Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients.
Richard P Mattick, Robert Ali, Jason M White, Susannah O'Brien, Seija Wolk, Cath Danz. Addiction 2003
186
7

Three methods of opioid detoxification in a primary care setting. A randomized trial.
P G O'Connor, K M Carroll, J M Shi, R S Schottenfeld, T R Kosten, B J Rounsaville. Ann Intern Med 1997
136
7

Buprenorphine: how to use it right.
Rolley E Johnson, Eric C Strain, Leslie Amass. Drug Alcohol Depend 2003
163
7

Comparison of buprenorphine and methadone in the treatment of opioid dependence.
E C Strain, M L Stitzer, I A Liebson, G E Bigelow. Am J Psychiatry 1994
209
7


The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?
Lynn E Sullivan, Marek Chawarski, Patrick G O'Connor, Richard S Schottenfeld, David A Fiellin. Drug Alcohol Depend 2005
90
7


Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network.
Lori J Ducharme, Hannah K Knudsen, Paul M Roman, J Aaron Johnson. J Subst Abuse Treat 2007
84
7

Smoking cessation treatment in community-based substance abuse rehabilitation programs.
Malcolm S Reid, Bryan Fallon, Susan Sonne, Frank Flammino, Edward V Nunes, Huiping Jiang, Eva Kourniotis, Jennifer Lima, Ron Brady, Cynthia Burgess,[...]. J Subst Abuse Treat 2008
95
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.